Felix Baker
Sits on 16 boards. Overboarded · 16 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 16
- Current seats
- 16
- Board service
- 47 years
- Director since
- 2023
47 years of board service in total across 16 boards, counting each seat separately. Longest: Incyte Corp., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202683.3%
-
Kymera Therapeutics Inc. June 25, 202587.8%
-
Kiniksa Pharmaceuticals International plc June 3, 202575.3%
-
Kiniksa Pharmaceuticals International plc June 5, 202466.9%
-
Kodiak Sciences Inc June 4, 202467.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Incyte Corp. | Grant or award | +400 | — | — |
| Jun 30, 2026 | Incyte Corp. | Grant or award | +400 | — | — |
| Jan 2, 2026 | Bicycle Therapeutics plc | Grant or award | +19,000 | — | — |
| Jan 2, 2026 | Bicycle Therapeutics plc | Grant or award | +19,000 | — | — |
| Dec 31, 2025 | Incyte Corp. | Grant or award | +328 | — | — |
| Dec 31, 2025 | Incyte Corp. | Grant or award | +328 | — | — |
| Dec 11, 2025 | Kymera Therapeutics Inc. | Open-market purchase | +167,192 | $86.00 | $14,378,512 |
| Dec 11, 2025 | Kymera Therapeutics Inc. | Open-market purchase | +1,838,621 | $86.00 | $158,121,406 |
| Nov 20, 2025 | Entrada Therapeutics Inc. | Open-market purchase | +1,213 | $9.07 | $11,002 |
| Nov 20, 2025 | Entrada Therapeutics Inc. | Open-market purchase | +13,386 | $9.07 | $121,411 |
| Nov 20, 2025 | Entrada Therapeutics Inc. | Open-market purchase | +1,186 | $9.07 | $10,757 |
| Nov 20, 2025 | Entrada Therapeutics Inc. | Open-market purchase | +13,082 | $9.07 | $118,654 |
| Sep 30, 2025 | Incyte Corp. | Grant or award | +388 | — | — |
| Sep 30, 2025 | Incyte Corp. | Grant or award | +388 | — | — |
| Aug 18, 2025 | Madrigal Pharmaceuticals Inc. | Open-market purchase | +177 | $353.88 | $62,637 |
Questions about Felix Baker
What boards is Felix Baker on?
Felix Baker sits on the boards of ACADIA Pharmaceuticals Inc., BeOne Medicines Ltd., Bicycle Therapeutics plc, DBV Technologies S.A., Denali Therapeutics Inc., Immunocore Holdings plc, Incyte Corp., Kiniksa Pharmaceuticals International plc, Kodiak Sciences Inc, Kymera Therapeutics Inc. and 6 others.
How long has Felix Baker served on boards?
Our records show at least 47 years of board service across 16 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.